Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EEG Analysis for the Objective Assessment of Secondary Hypersomnolence in Order to Limit the Accidental Risk

NCT05453643 is registered in ClinicalTrials.gov with Physip S.A as lead sponsor.

NCT NCT05453643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05453643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EEG Analysis for the Objective Assessment of Secondary Hypersomnolence in Order to Limit the Accidental Risk
Lead sponsor
Physip S.A
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 8, 2023
Completion date
June 30, 2027
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep deprivation